Real-world safety and efficacy of lecanemab in the treatment of Alzheimer's disease: a systematic review and meta-analysis.
This systematic review and meta-analysis pooled real-world studies of lecanemab treatment in people with Alzheimer’s disease, including 37 studies.
Why it matters
Real-world pooled estimates provide context for lecanemab safety beyond controlled trials, including variation in ARIA rates by APOE ε4 status and baseline microhemorrhage.